Abstracts tagged "Body mass and juvenile idiopathic arthritis (JIA)"

Abstract Number: 394 • 2016 ACR/ARHP Annual Meeting
Effect of BMI on Symptoms and Outcomes in Juvenile Idiopathic Arthritis Patients
Jennifer E. Weiss¹, Tracy Andrews², Esi Morgan³, Ronald Laxer⁴, Cagri Yildirim-Toruner⁵, C. April Bingham⁶, Beth Gottlieb⁷, Tzielan Lee⁸, Sheetal S. Vora⁹, Jon M. Burnham¹⁰, Judyann C. Olson¹¹, Murray Passo¹², Michelle Batthish¹³ and Meredith Riebschleger¹⁴, ¹Hackensack Univ Med Ctr, Hackensack, NJ, ²Biostatistics, David & Alice Jurist Institute, Hackensack University Medical Center, hackensack, NJ, ³Pediatric Rheumatology, Cincinnati Children's Hospital, Cincinnati, OH, ⁴Div of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ⁵Rheumatology, Nationwide Children's Hospital, Columbus, OH, ⁶Penn State Health Children's Hospital, Hershey, PA, ⁷Pediatric Rheumatology PTD, Cohen Children's Medical Center of New York, Lake Success, NY, ⁸Dept of Pediatric Rheumatology, Stanford Univ School of Med, Palo Alto, CA, ⁹Pediatric Rheumatology, Medical College of Wisconsin, Milwaukee, WI, ¹⁰Pediatric Rheumatology, Children's Hospital Philadelphia, Philadelphia, PA, ¹¹Ped/MACC Fund Research Ctr, Medical College of Wisconsin, Milwaukee, WI, ¹²Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC, ¹³Division of Pediatric Rheumatology, McMaster Children's Hospital, Hamilton, ON, Canada, ¹⁴Pediatric Rheumatology, University of Michigan, CS Mott Children's Hospiatl, Ann Arbor, MI
Background/Purpose: Children with JIA are at risk for cardiovascular disease and obesity compounds this risk. There is limited data on the prevalence of elevated BMI…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].